The global market for Erythropoietin (EPO) was valued at US$ 10280 million in the year 2024 and is projected to reach a revised size of US$ 15170 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Erythropoietin (EPO) Market

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml

The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Erythropoietin (EPO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythropoietin (EPO).

The Erythropoietin (EPO) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erythropoietin (EPO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Erythropoietin (EPO) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Erythropoietin (EPO) Market Report

Report Metric	Details
Report Name	Erythropoietin (EPO) Market
Accounted market size in year	US$ 10280 million
Forecasted market size in 2031	US$ 15170 million
CAGR	5.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Epoetin-alfa Darbepoetin-alfa Epoetin-beta Others
Segment by Application	Anemia Kidney Disorders Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon, LG Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erythropoietin (EPO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erythropoietin (EPO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Erythropoietin (EPO) Market growing?

Ans: The Erythropoietin (EPO) Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Erythropoietin (EPO) Market size in 2031?

Ans: The Erythropoietin (EPO) Market size in 2031 will be US$ 15170 million.

What is the market share of major companies in Erythropoietin (EPO) Market?

Ans: The top 2 players occupy about 60% shares of the global market.

What is the Erythropoietin (EPO) Market share by region?

Ans: North America is the main market, and occupies over 65% of the global market.

What is the Erythropoietin (EPO) Market share by type?

Ans: Epoetin-alfa is the main type, with a share about 80%.

What is the Erythropoietin (EPO) Market share by application?

Ans: Kidney Disorders is the key application, which holds a share over 40%.

Who are the main players in the Erythropoietin (EPO) Market report?

Ans: The main players in the Erythropoietin (EPO) Market are Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon, LG Life Sciences

What are the Application segmentation covered in the Erythropoietin (EPO) Market report?

Ans: The Applications covered in the Erythropoietin (EPO) Market report are Anemia, Kidney Disorders, Other

What are the Type segmentation covered in the Erythropoietin (EPO) Market report?

Ans: The Types covered in the Erythropoietin (EPO) Market report are Epoetin-alfa, Darbepoetin-alfa, Epoetin-beta, Others

1 Erythropoietin (EPO) Market Overview

1.1 Product Definition

1.2 Erythropoietin (EPO) by Type

1.2.1 Global Erythropoietin (EPO) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Epoetin-alfa

1.2.3 Darbepoetin-alfa

1.2.4 Epoetin-beta

1.2.5 Others

1.3 Erythropoietin (EPO) by Application

1.3.1 Global Erythropoietin (EPO) Market Value by Application (2024 VS 2031)

1.3.2 Anemia

1.3.3 Kidney Disorders

1.3.4 Other

1.4 Global Erythropoietin (EPO) Market Size Estimates and Forecasts

1.4.1 Global Erythropoietin (EPO) Revenue 2020-2031

1.4.2 Global Erythropoietin (EPO) Sales 2020-2031

1.4.3 Global Erythropoietin (EPO) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Erythropoietin (EPO) Market Competition by Manufacturers

2.1 Global Erythropoietin (EPO) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Erythropoietin (EPO) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Erythropoietin (EPO) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Erythropoietin (EPO), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Erythropoietin (EPO), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Erythropoietin (EPO), Product Type & Application

2.7 Global Key Manufacturers of Erythropoietin (EPO), Date of Enter into This Industry

2.8 Global Erythropoietin (EPO) Market Competitive Situation and Trends

2.8.1 Global Erythropoietin (EPO) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Erythropoietin (EPO) Players Market Share by Revenue

2.8.3 Global Erythropoietin (EPO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Erythropoietin (EPO) Market Scenario by Region

3.1 Global Erythropoietin (EPO) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Erythropoietin (EPO) Sales by Region: 2020-2031

3.2.1 Global Erythropoietin (EPO) Sales by Region: 2020-2025

3.2.2 Global Erythropoietin (EPO) Sales by Region: 2026-2031

3.3 Global Erythropoietin (EPO) Revenue by Region: 2020-2031

3.3.1 Global Erythropoietin (EPO) Revenue by Region: 2020-2025

3.3.2 Global Erythropoietin (EPO) Revenue by Region: 2026-2031

3.4 North America Erythropoietin (EPO) Market Facts & Figures by Country

3.4.1 North America Erythropoietin (EPO) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Erythropoietin (EPO) Sales by Country (2020-2031)

3.4.3 North America Erythropoietin (EPO) Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Erythropoietin (EPO) Market Facts & Figures by Country

3.5.1 Europe Erythropoietin (EPO) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Erythropoietin (EPO) Sales by Country (2020-2031)

3.5.3 Europe Erythropoietin (EPO) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Erythropoietin (EPO) Market Facts & Figures by Region

3.6.1 Asia Pacific Erythropoietin (EPO) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Erythropoietin (EPO) Sales by Region (2020-2031)

3.6.3 Asia Pacific Erythropoietin (EPO) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Erythropoietin (EPO) Market Facts & Figures by Country

3.7.1 Latin America Erythropoietin (EPO) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Erythropoietin (EPO) Sales by Country (2020-2031)

3.7.3 Latin America Erythropoietin (EPO) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Erythropoietin (EPO) Market Facts & Figures by Country

3.8.1 Middle East and Africa Erythropoietin (EPO) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Erythropoietin (EPO) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Erythropoietin (EPO) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Erythropoietin (EPO) Sales by Type (2020-2031)

4.1.1 Global Erythropoietin (EPO) Sales by Type (2020-2025)

4.1.2 Global Erythropoietin (EPO) Sales by Type (2026-2031)

4.1.3 Global Erythropoietin (EPO) Sales Market Share by Type (2020-2031)

4.2 Global Erythropoietin (EPO) Revenue by Type (2020-2031)

4.2.1 Global Erythropoietin (EPO) Revenue by Type (2020-2025)

4.2.2 Global Erythropoietin (EPO) Revenue by Type (2026-2031)

4.2.3 Global Erythropoietin (EPO) Revenue Market Share by Type (2020-2031)

4.3 Global Erythropoietin (EPO) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Erythropoietin (EPO) Sales by Application (2020-2031)

5.1.1 Global Erythropoietin (EPO) Sales by Application (2020-2025)

5.1.2 Global Erythropoietin (EPO) Sales by Application (2026-2031)

5.1.3 Global Erythropoietin (EPO) Sales Market Share by Application (2020-2031)

5.2 Global Erythropoietin (EPO) Revenue by Application (2020-2031)

5.2.1 Global Erythropoietin (EPO) Revenue by Application (2020-2025)

5.2.2 Global Erythropoietin (EPO) Revenue by Application (2026-2031)

5.2.3 Global Erythropoietin (EPO) Revenue Market Share by Application (2020-2031)

5.3 Global Erythropoietin (EPO) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Amgen

6.1.1 Amgen Company Information

6.1.2 Amgen Description and Business Overview

6.1.3 Amgen Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Amgen Erythropoietin (EPO) Product Portfolio

6.1.5 Amgen Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Company Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Johnson & Johnson Erythropoietin (EPO) Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Roche

6.3.1 Roche Company Information

6.3.2 Roche Description and Business Overview

6.3.3 Roche Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Roche Erythropoietin (EPO) Product Portfolio

6.3.5 Roche Recent Developments/Updates

6.4 Galenica

6.4.1 Galenica Company Information

6.4.2 Galenica Description and Business Overview

6.4.3 Galenica Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Galenica Erythropoietin (EPO) Product Portfolio

6.4.5 Galenica Recent Developments/Updates

6.5 Emcure

6.5.1 Emcure Company Information

6.5.2 Emcure Description and Business Overview

6.5.3 Emcure Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Emcure Erythropoietin (EPO) Product Portfolio

6.5.5 Emcure Recent Developments/Updates

6.6 Kyowa Hakko Kirin

6.6.1 Kyowa Hakko Kirin Company Information

6.6.2 Kyowa Hakko Kirin Description and Business Overview

6.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Kyowa Hakko Kirin Erythropoietin (EPO) Product Portfolio

6.6.5 Kyowa Hakko Kirin Recent Developments/Updates

6.7 3SBio

6.7.1 3SBio Company Information

6.7.2 3SBio Description and Business Overview

6.7.3 3SBio Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 3SBio Erythropoietin (EPO) Product Portfolio

6.7.5 3SBio Recent Developments/Updates

6.8 Biocon

6.8.1 Biocon Company Information

6.8.2 Biocon Description and Business Overview

6.8.3 Biocon Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Biocon Erythropoietin (EPO) Product Portfolio

6.8.5 Biocon Recent Developments/Updates

6.9 LG Life Sciences

6.9.1 LG Life Sciences Company Information

6.9.2 LG Life Sciences Description and Business Overview

6.9.3 LG Life Sciences Erythropoietin (EPO) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 LG Life Sciences Erythropoietin (EPO) Product Portfolio

6.9.5 LG Life Sciences Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Erythropoietin (EPO) Industry Chain Analysis

7.2 Erythropoietin (EPO) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Erythropoietin (EPO) Production Mode & Process Analysis

7.4 Erythropoietin (EPO) Sales and Marketing

7.4.1 Erythropoietin (EPO) Sales Channels

7.4.2 Erythropoietin (EPO) Distributors

7.5 Erythropoietin (EPO) Customer Analysis

8 Erythropoietin (EPO) Market Dynamics

8.1 Erythropoietin (EPO) Industry Trends

8.2 Erythropoietin (EPO) Market Drivers

8.3 Erythropoietin (EPO) Market Challenges

8.4 Erythropoietin (EPO) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Erythropoietin (EPO) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Erythropoietin (EPO) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Erythropoietin (EPO) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Erythropoietin (EPO) Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Erythropoietin (EPO) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Erythropoietin (EPO) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Erythropoietin (EPO) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Erythropoietin (EPO) Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Erythropoietin (EPO), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Erythropoietin (EPO), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Erythropoietin (EPO), Product Type & Application

Table 12. Global Key Manufacturers of Erythropoietin (EPO), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Erythropoietin (EPO) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin (EPO) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Erythropoietin (EPO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Erythropoietin (EPO) Sales by Region (2020-2025) & (Units)

Table 18. Global Erythropoietin (EPO) Sales Market Share by Region (2020-2025)

Table 19. Global Erythropoietin (EPO) Sales by Region (2026-2031) & (Units)

Table 20. Global Erythropoietin (EPO) Sales Market Share by Region (2026-2031)

Table 21. Global Erythropoietin (EPO) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Erythropoietin (EPO) Revenue Market Share by Region (2020-2025)

Table 23. Global Erythropoietin (EPO) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Erythropoietin (EPO) Revenue Market Share by Region (2026-2031)

Table 25. North America Erythropoietin (EPO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Erythropoietin (EPO) Sales by Country (2020-2025) & (Units)

Table 27. North America Erythropoietin (EPO) Sales by Country (2026-2031) & (Units)

Table 28. North America Erythropoietin (EPO) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Erythropoietin (EPO) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Erythropoietin (EPO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Erythropoietin (EPO) Sales by Country (2020-2025) & (Units)

Table 32. Europe Erythropoietin (EPO) Sales by Country (2026-2031) & (Units)

Table 33. Europe Erythropoietin (EPO) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Erythropoietin (EPO) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Erythropoietin (EPO) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Erythropoietin (EPO) Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Erythropoietin (EPO) Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Erythropoietin (EPO) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Erythropoietin (EPO) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Erythropoietin (EPO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Erythropoietin (EPO) Sales by Country (2020-2025) & (Units)

Table 42. Latin America Erythropoietin (EPO) Sales by Country (2026-2031) & (Units)

Table 43. Latin America Erythropoietin (EPO) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Erythropoietin (EPO) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Erythropoietin (EPO) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Erythropoietin (EPO) Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Erythropoietin (EPO) Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Erythropoietin (EPO) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Erythropoietin (EPO) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Erythropoietin (EPO) Sales (Units) by Type (2020-2025)

Table 51. Global Erythropoietin (EPO) Sales (Units) by Type (2026-2031)

Table 52. Global Erythropoietin (EPO) Sales Market Share by Type (2020-2025)

Table 53. Global Erythropoietin (EPO) Sales Market Share by Type (2026-2031)

Table 54. Global Erythropoietin (EPO) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Erythropoietin (EPO) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Erythropoietin (EPO) Revenue Market Share by Type (2020-2025)

Table 57. Global Erythropoietin (EPO) Revenue Market Share by Type (2026-2031)

Table 58. Global Erythropoietin (EPO) Price (USD/Unit) by Type (2020-2025)

Table 59. Global Erythropoietin (EPO) Price (USD/Unit) by Type (2026-2031)

Table 60. Global Erythropoietin (EPO) Sales (Units) by Application (2020-2025)

Table 61. Global Erythropoietin (EPO) Sales (Units) by Application (2026-2031)

Table 62. Global Erythropoietin (EPO) Sales Market Share by Application (2020-2025)

Table 63. Global Erythropoietin (EPO) Sales Market Share by Application (2026-2031)

Table 64. Global Erythropoietin (EPO) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Erythropoietin (EPO) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Erythropoietin (EPO) Revenue Market Share by Application (2020-2025)

Table 67. Global Erythropoietin (EPO) Revenue Market Share by Application (2026-2031)

Table 68. Global Erythropoietin (EPO) Price (USD/Unit) by Application (2020-2025)

Table 69. Global Erythropoietin (EPO) Price (USD/Unit) by Application (2026-2031)

Table 70. Amgen Company Information

Table 71. Amgen Description and Business Overview

Table 72. Amgen Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Amgen Erythropoietin (EPO) Product

Table 74. Amgen Recent Developments/Updates

Table 75. Johnson & Johnson Company Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Johnson & Johnson Erythropoietin (EPO) Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Roche Company Information

Table 81. Roche Description and Business Overview

Table 82. Roche Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Roche Erythropoietin (EPO) Product

Table 84. Roche Recent Developments/Updates

Table 85. Galenica Company Information

Table 86. Galenica Description and Business Overview

Table 87. Galenica Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Galenica Erythropoietin (EPO) Product

Table 89. Galenica Recent Developments/Updates

Table 90. Emcure Company Information

Table 91. Emcure Description and Business Overview

Table 92. Emcure Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Emcure Erythropoietin (EPO) Product

Table 94. Emcure Recent Developments/Updates

Table 95. Kyowa Hakko Kirin Company Information

Table 96. Kyowa Hakko Kirin Description and Business Overview

Table 97. Kyowa Hakko Kirin Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Kyowa Hakko Kirin Erythropoietin (EPO) Product

Table 99. Kyowa Hakko Kirin Recent Developments/Updates

Table 100. 3SBio Company Information

Table 101. 3SBio Description and Business Overview

Table 102. 3SBio Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. 3SBio Erythropoietin (EPO) Product

Table 104. 3SBio Recent Developments/Updates

Table 105. Biocon Company Information

Table 106. Biocon Description and Business Overview

Table 107. Biocon Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Biocon Erythropoietin (EPO) Product

Table 109. Biocon Recent Developments/Updates

Table 110. LG Life Sciences Company Information

Table 111. LG Life Sciences Description and Business Overview

Table 112. LG Life Sciences Erythropoietin (EPO) Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. LG Life Sciences Erythropoietin (EPO) Product

Table 114. LG Life Sciences Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Erythropoietin (EPO) Distributors List

Table 118. Erythropoietin (EPO) Customers List

Table 119. Erythropoietin (EPO) Market Trends

Table 120. Erythropoietin (EPO) Market Drivers

Table 121. Erythropoietin (EPO) Market Challenges

Table 122. Erythropoietin (EPO) Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Erythropoietin (EPO)

Figure 2. Global Erythropoietin (EPO) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Erythropoietin (EPO) Market Share by Type: 2024 & 2031

Figure 4. Epoetin-alfa Product Picture

Figure 5. Darbepoetin-alfa Product Picture

Figure 6. Epoetin-beta Product Picture

Figure 7. Others Product Picture

Figure 8. Global Erythropoietin (EPO) Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Erythropoietin (EPO) Market Share by Application: 2024 & 2031

Figure 10. Anemia

Figure 11. Kidney Disorders

Figure 12. Other

Figure 13. Global Erythropoietin (EPO) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Erythropoietin (EPO) Market Size (2020-2031) & (US$ Million)

Figure 15. Global Erythropoietin (EPO) Sales (2020-2031) & (Units)

Figure 16. Global Erythropoietin (EPO) Average Price (USD/Unit) & (2020-2031)

Figure 17. Erythropoietin (EPO) Report Years Considered

Figure 18. Erythropoietin (EPO) Sales Share by Manufacturers in 2024

Figure 19. Global Erythropoietin (EPO) Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Erythropoietin (EPO) Players: Market Share by Revenue in Erythropoietin (EPO) in 2024

Figure 21. Erythropoietin (EPO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Erythropoietin (EPO) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Erythropoietin (EPO) Sales Market Share by Country (2020-2031)

Figure 24. North America Erythropoietin (EPO) Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Erythropoietin (EPO) Sales Market Share by Country (2020-2031)

Figure 28. Europe Erythropoietin (EPO) Revenue Market Share by Country (2020-2031)

Figure 29. Germany Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Erythropoietin (EPO) Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Erythropoietin (EPO) Revenue Market Share by Region (2020-2031)

Figure 36. China Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Erythropoietin (EPO) Sales Market Share by Country (2020-2031)

Figure 47. Latin America Erythropoietin (EPO) Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Erythropoietin (EPO) Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Erythropoietin (EPO) Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Erythropoietin (EPO) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Erythropoietin (EPO) by Type (2020-2031)

Figure 57. Global Revenue Market Share of Erythropoietin (EPO) by Type (2020-2031)

Figure 58. Global Erythropoietin (EPO) Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Erythropoietin (EPO) by Application (2020-2031)

Figure 60. Global Revenue Market Share of Erythropoietin (EPO) by Application (2020-2031)

Figure 61. Global Erythropoietin (EPO) Price (USD/Unit) by Application (2020-2031)

Figure 62. Erythropoietin (EPO) Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Erythropoietin (EPO) Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-37I9239

Global Erythropoietin (EPO) Market Research Report 2025

FEATURED COMPANIES

Erythropoietin (EPO) Market Size

Erythropoietin (EPO) Market

Report Scope

Scope of Erythropoietin (EPO) Market Report

Core Chapters

FAQ for this report

How fast is Erythropoietin (EPO) Market growing?

What is the Erythropoietin (EPO) Market size in 2031?

What is the market share of major companies in Erythropoietin (EPO) Market?

What is the Erythropoietin (EPO) Market share by region?

What is the Erythropoietin (EPO) Market share by type?

What is the Erythropoietin (EPO) Market share by application?

Who are the main players in the Erythropoietin (EPO) Market report?

What are the Application segmentation covered in the Erythropoietin (EPO) Market report?

What are the Type segmentation covered in the Erythropoietin (EPO) Market report?

FEATURED COMPANIES

RELATED REPORTS